BMRN – BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical Inc.

BMRN

$53.31

Name : BioMarin Pharmaceutical Inc.

Sector : Healthcare

Industry: Biotechnology

Mark. Cap: $10,241,615,872.00

EPSttm : 2.69

BioMarin Pharmaceutical Inc.

$53.31

0.60%

$0.32

Float Short %

4.35

Margin Of Safety %

Put/Call OI Ratio

0.44

EPS Next Q Diff

1.14

EPS Last/This Y

1.32

EPS This/Next Y

1.68

Price

53.29

Target Price

88.71

Analyst Recom

1.66

Performance Q

0.32

Relative Volume

0.59

Beta

0.27

Ticker: BMRN

20 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2025-11-13	BMRN	54.22	0.51	1.14	39532
2025-11-14	BMRN	54.74	0.52	0.26	39754
2025-11-17	BMRN	54.47	0.52	0.51	39911
2025-11-18	BMRN	54.15	0.52	0.17	40362
2025-11-19	BMRN	52.53	0.49	0.48	42342
2025-11-20	BMRN	52.46	0.49	0.20	42737
2025-11-21	BMRN	54.67	0.48	0.05	43746
2025-11-24	BMRN	55.47	0.52	0.08	37566
2025-11-25	BMRN	56.32	0.50	0.33	38607
2025-11-26	BMRN	55.48	0.49	0.03	39711
2025-12-01	BMRN	55.02	0.46	2.50	41576
2025-12-02	BMRN	53.88	0.46	0.38	41671
2025-12-03	BMRN	54.3	0.46	2.03	41511
2025-12-04	BMRN	53.81	0.46	0.02	41500
2025-12-05	BMRN	53.4	0.46	0.26	41142
2025-12-08	BMRN	53.3	0.46	0.20	41139
2025-12-09	BMRN	53.73	0.45	0.70	41477
2025-12-10	BMRN	53.69	0.47	0.18	41717
2025-12-11	BMRN	52.97	0.46	0.40	41905
2025-12-12	BMRN	53.3	0.44	0.61	41634
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

20 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-11-13	BMRN	54.22	1.1	328.1	3.57
2025-11-14	BMRN	54.75	1.1	361.5	3.57
2025-11-17	BMRN	54.45	1.1	344.6	3.57
2025-11-18	BMRN	54.13	1.1	343.5	3.57
2025-11-19	BMRN	52.56	1.1	316.8	3.57
2025-11-20	BMRN	52.50	1.1	349.1	3.57
2025-11-21	BMRN	54.68	0.6	397.4	3.58
2025-11-24	BMRN	55.48	0.6	367.1	3.58
2025-11-25	BMRN	56.29	0.6	366.9	3.58
2025-11-26	BMRN	55.47	0.6	333.9	3.58
2025-12-01	BMRN	55.04	0.6	332.3	3.58
2025-12-02	BMRN	53.89	0.6	327.1	3.58
2025-12-03	BMRN	54.31	0.6	359.3	3.58
2025-12-04	BMRN	53.85	0.6	340.6	3.58
2025-12-05	BMRN	53.40	0.6	341.5	3.58
2025-12-08	BMRN	53.30	0.6	-	3.57
2025-12-09	BMRN	53.74	0.6	359.7	3.57
2025-12-10	BMRN	53.74	0.6	348.7	3.57
2025-12-11	BMRN	52.99	0.6	335.2	3.57
2025-12-12	BMRN	53.29	0.6	356.9	3.57
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-11-13	BMRN	-0.06	-2.31	5.21
2025-11-14	BMRN	-0.06	-2.31	5.21
2025-11-17	BMRN	-0.06	0.87	5.21
2025-11-18	BMRN	-0.06	0.87	5.21
2025-11-19	BMRN	-0.06	0.87	5.21
2025-11-20	BMRN	-0.06	0.87	5.21
2025-11-21	BMRN	0.00	0.87	5.21
2025-11-24	BMRN	0.00	-1.20	5.21
2025-11-25	BMRN	0.00	-1.20	5.21
2025-11-26	BMRN	0.00	-1.20	4.73
2025-12-01	BMRN	0.00	-1.61	4.73
2025-12-02	BMRN	0.00	-1.61	4.73
2025-12-03	BMRN	0.00	-1.61	4.73
2025-12-04	BMRN	0.00	-1.61	4.73
2025-12-05	BMRN	0.00	-1.61	4.73
2025-12-08	BMRN	0.00	-1.38	4.73
2025-12-09	BMRN	0.00	-1.38	4.73
2025-12-10	BMRN	0.00	-1.38	4.35
2025-12-11	BMRN	0.00	-1.38	4.35
2025-12-12	BMRN	0.00	-1.38	4.35
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

[stock_market_widget type="chart" template="candlestick" assets="BMRN" range="1y" interval="1d" price_field="close" heading="{symbol}" candle_border_width="1" candle_bullish_background_color="#21BA45" candle_bearish_background_color="#DB2828" candle_bullish_border_color="#21BA45" candle_bearish_border_color="#DB2828" axes_color="#000000" tooltip_text_color="#262626" tooltip_background_color="#ffffff" range_selector="true" volume_enabled="true" axes_enabled="true" tooltip_enabled="false" zoom_enabled="true" save_image_enabled="true" volume_bar_fill_color="#5679FF" api="yahoo-finance"]

Last Quarter Act. EPS

0.12

Avg. EPS Est. Current Quarter

0.93

Avg. EPS Est. Next Quarter

1.26

Insider Transactions

Institutional Transactions

-1.38

Beta

0.27

Average Sales Estimate Current Quarter

823

Average Sales Estimate Next Quarter

818

Fair Value

70.76

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

54.8

Max Drawdown 5-Year %

-56.1

Target Price

88.71

P/E

19.97

Forward P/E

11.75

PEG

0.36

P/S

3.32

P/B

1.69

P/Free Cash Flow

12.31

EPS

2.67

Average EPS Est. Cur. Y

3.57

EPS Next Y. (Est.)

5.26

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

16.87

Relative Volume

0.59

Return on Equity vs Sector %

-18.3

Return on Equity vs Industry %

-3.3

EPS 1 7Days Diff

EPS 1 30Days Diff

0.01

EBIT Estimation

356.9

[stock_market_widget type=”table-options” template=”gradient” color=”#5679FF” assets=”BMRN” fields=”contract_symbol,type,strike,price,change_pct,implied_volatility,change_abs,open_interest,volume,in_the_money,bid,ask” pagination=”true” rows_per_page=”21″ sort_direction=”asc” alignment=”left” search=”true” sort_field=”strike” api=”yahoo-finance”]

[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”BMRN” options_type=”calls” x_axis_field=”strike” y_axis_field=”price” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]

[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”BMRN” options_type=”puts” x_axis_field=”strike” y_axis_field=”price” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]

[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”BMRN” options_type=”calls” x_axis_field=”strike” y_axis_field=”implied_volatility” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]

[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”BMRN” options_type=”puts” x_axis_field=”strike” y_axis_field=”implied_volatility” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]

[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”BMRN” options_type=”calls” x_axis_field=”strike” y_axis_field=”volume” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]

[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”BMRN” options_type=”puts” x_axis_field=”strike” y_axis_field=”volume” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]

BioMarin Pharmaceutical Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 3040

BioMarin Pharmaceutical Inc., a biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States, Europe, Latin America, the Middle East, the Asia Pacific, and internationally. The company's products include VIMIZIM, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; VOXZOGO, a once daily injection analog of c-type natriuretic peptide (CNP) for the treatment of achondroplasia; NAGLAZYME, a recombinant form of N- acetylgalactosamine 4-sulfatase for patients with MPS VI; and PALYNZIQ, a PEGylated recombinant phenylalanine (Phe) ammonia lyase enzyme delivered through subcutaneous injection to reduce blood Phe concentrations. It also develops BRINEURA, a recombinant human tripeptidyl peptidase 1 for the treatment of patients with ceroid lipofuscinosis type 2, a form of Batten disease; ALDURAZYME, a purified protein designed to be identical to a naturally occurring form of the human enzyme alpha-L-iduronidase; KUVAN, a proprietary synthetic oral form of 6R-BH4 that is used to treat patients with phenylketonuria, an inherited metabolic disease; and ROCTAVIAN, an adeno associated virus vector for the treatment of severe hemophilia A. The company's products under development include BMN 333, a longer-acting CNP for the treatment of multiple growth disorders, such as achondroplasia and hypochondroplasia; BMN 349, an oral therapeutic for the treatment of liver disease associated with alpha-1 antitrypsin deficiency; and BMN 351, an oligonucleotide for the treatment of duchenne muscular dystrophy. It serves specialty pharmacies, hospitals, non-U.S. government agencies, distributors, and pharmaceutical wholesalers. The company has license and collaboration agreements with Catalyst Pharmaceutical Partners, Inc., and Ares Trading S.A. The company was incorporated in 1996 and is based in San Rafael, California.

stock quote shares BMRN – BioMarin Pharmaceutical Inc. Stock Price stock today

news today BMRN – BioMarin Pharmaceutical Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch BMRN – BioMarin Pharmaceutical Inc. yahoo finance google finance

stock history BMRN – BioMarin Pharmaceutical Inc. invest stock market

stock prices BMRN premarket after hours

ticker BMRN fair value insiders trading

BMRN – BioMarin Pharmaceutical Inc.

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: BMRN

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Last Quarter Act. EPS

Average EPS Est. Cur. Y